Related Experiment Video

Updated: Jan 20, 2026

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
09:08

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on: July 27, 2021

4.1K

Serum antibody to respiratory syncytial virus in goats in the UK

K L Morgan, R A Kyle, H T Martin

    The Veterinary Record
    |March 2, 1985
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.5K
    An Assay to Measure the Neutralizing Antibody Titer Specific for Respiratory Syncytial Virus05:01

    An Assay to Measure the Neutralizing Antibody Titer Specific for Respiratory Syncytial Virus

    715

    Related Concept Videos

    Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus09:08

    Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

    For in-depth mechanistic analysis of the respiratory syncytial virus (RSV) RNA synthesis, we report a protocol of utilizing the chaperone phosphoprotein (P) for coexpression of the RNA-free nucleoprotein (N0) for subsequent in vitro assembly of the virus-specific nucleocapsids...
    4.1K
    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

    We present a protocol for using a protein microarray constructed by printing influenza antigens onto nitrocellulose-coated slides to simultaneously probe serum for multiple antibody isotypes against over 250 antigens from different virus strains, thus allowing measurement of the breadth of serum antibodies across virus...
    8.5K
    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

    We describe a method for generating and amplifying genetically modified respiratory syncytial viruses (RSVs) and an optimized plaque assay for RSVs. We illustrate this protocol by creating two recombinant viruses that respectively allow quantification of RSV replication and live analysis of RSV inclusion bodies and inclusion bodies-associated granules...
    17.0K
    An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

    An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

    This study describes a high throughput, imaging-based micro-neutralization assay to determine the titer of neutralizing antibodies specific for respiratory syncytial virus (RSV). This assay format has been tested on different sample...
    11.5K
    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Human respiratory syncytial virus (HRSV) can cause severe bronchiolitis in young infants. Part of the pathogenesis of severe HRSV disease is caused by the host immune response. Stimulation of primary human immune cells with HRSV provides a fast and reproducible model system to study activation of inflammatory pathways and...
    8.3K
    An Assay to Measure the Neutralizing Antibody Titer Specific for Respiratory Syncytial Virus05:01

    An Assay to Measure the Neutralizing Antibody Titer Specific for Respiratory Syncytial Virus

    This video demonstrates an assay for measuring neutralizing antibodies against respiratory syncytial virus (RSV). Pre-incubation with serum containing RSV-neutralizing antibodies neutralizes the virus particles, reducing cellular infection and plaque formation. Virus-infected cells are then subjected to fixation, blocking, and fluorophore-conjugated antibody labeling for plaque visualization. This process enables the identification of the highest serum dilution that neutralizes fifty percent of...
    715